| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/10/2003 | CA2462424A1 A novel g protein-coupled receptor, gave 10 |
| 04/10/2003 | CA2462162A1 Identification of new cd8 epitopes from hiv-1 proteins with therapeuticaal and vaccinal properties against hiv infections |
| 04/10/2003 | CA2462113A1 Multi-chain eukaryotic display vectors and uses thereof |
| 04/10/2003 | CA2462077A1 Fluorescent proteins |
| 04/10/2003 | CA2461998A1 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 04/10/2003 | CA2461292A1 Apo-2 ligand variants and uses thereof |
| 04/10/2003 | CA2460917A1 Human tissue factor antibodies |
| 04/10/2003 | CA2460916A1 Methods and compositions for modulating interleukin-21 receptor activity |
| 04/10/2003 | CA2455389A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 04/10/2003 | CA2455225A1 Novel proteins and nucleic acids encoding same |
| 04/09/2003 | EP1300468A2 TRNA synthetase |
| 04/09/2003 | EP1300419A1 Antibody of human origin for inhibiting thrombocyte aggregation |
| 04/09/2003 | EP1300156A2 Otitis media vaccine |
| 04/09/2003 | EP1299556A2 Host cells containing multiple integrating vectors |
| 04/09/2003 | EP1299546A2 Aminoacyl trna synthetases |
| 04/09/2003 | EP1299545A2 Drug metabolizing enzymes |
| 04/09/2003 | EP1299544A2 Fimh adhesin proteins and methods of use |
| 04/09/2003 | EP1299541A2 Method for producing and using novel human defensins as biologically active proteins for treating infections and other illnesses |
| 04/09/2003 | EP1299538A2 Secreted proteins |
| 04/09/2003 | EP1299535A2 Peptide extended glycosylated polypeptides |
| 04/09/2003 | EP1299530A2 Novel compounds |
| 04/09/2003 | EP1299528A1 Human olfactory receptors and genes encoding same |
| 04/09/2003 | EP1299526A1 Method for the production of hydroxylated collagen-like compounds |
| 04/09/2003 | EP1299524A1 Human myeloma cell line |
| 04/09/2003 | EP1299522A2 Alteration of cell membrane |
| 04/09/2003 | EP1299421A2 Antibodies to human mcp-1 |
| 04/09/2003 | EP1299419A2 Bispecific immunoglobulin-like antigen binding proteins and method of production |
| 04/09/2003 | EP1299415A1 Chemokine receptor modulators, production and use |
| 04/09/2003 | EP1299414A2 Fluorescent proteins |
| 04/09/2003 | EP1299412A2 Protein modification and maintenance molecules |
| 04/09/2003 | EP1299327A2 Phosphorylated polypeptides and uses related thereto |
| 04/09/2003 | EP0984703B1 Methods of producing protein hydrolysates |
| 04/09/2003 | EP0840748B1 Transforming growth factor beta crystals |
| 04/09/2003 | EP0804552B1 Redirection of cellular immunity by receptor chimeras |
| 04/09/2003 | EP0795608B1 Antithrombotic agent and anti-von willebrand factor monoclonal antibodies |
| 04/09/2003 | EP0784685B1 Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor |
| 04/09/2003 | EP0779933B1 Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
| 04/09/2003 | EP0758384B1 Leishmania major protein, nucleic acid coding therefor, and uses thereof |
| 04/09/2003 | EP0723455B1 Method of inhibiting phagocytosis |
| 04/09/2003 | EP0722462B1 Dna encoding prostaglandin receptor ip |
| 04/09/2003 | EP0708831B1 Cell-density enhanced protein tyrosine phosphatases |
| 04/09/2003 | EP0675956B1 New protein from urine named component b |
| 04/09/2003 | CN1409764A Pseudomonas aeruginosa antigens |
| 04/09/2003 | CN1409755A Production of peptides by fedbatch cultivation of microoganism |
| 04/09/2003 | CN1409114A REG sample protein |
| 04/09/2003 | CN1408880A Detecting and trapping receptor 3 monoclonal antibody, hybrid tumor for producing said antibody and its use |
| 04/09/2003 | CN1408874A Procaryotic cell in vivo antibody library construction screening and optimizing of antibody and use |
| 04/09/2003 | CN1408873A process for efficiently purifying gene engineering bacteria recombination expression product and its use |
| 04/09/2003 | CN1408866A Human fertilization promotion peptide receptor TCP11 and its coding sequence and preparation and use |
| 04/09/2003 | CN1408863A Human interleukin-10 gene sequenc and E coli containing the said gene sequence |
| 04/09/2003 | CN1408860A New human primary azoospermatism relative zinc finger protein and coding sequence and preparation and use |
| 04/09/2003 | CN1408856A X-propyl-dipeptide amino peptidase from lactic acid coccus and its preparation and use |
| 04/09/2003 | CN1408849A Process for preparing recombination human glicentin-1(7-37) |
| 04/09/2003 | CN1408725A Process for preparing human blood platelet glucoprotein GPIb alpha and its special primer |
| 04/09/2003 | CN1408724A Novel testicular function relative protein and its use |
| 04/09/2003 | CN1408429A Preparation of extramembranou section of therapeutic protein B lymphocyte stimulation factor |
| 04/09/2003 | CN1105187C Protocadherin proteins and their use |
| 04/09/2003 | CN1105186C Gene imparting flocculability to yeast and gene product |
| 04/09/2003 | CN1105184C Enzyme with protease activity |
| 04/09/2003 | CN1105183C Microbial process for producing transglutaminase |
| 04/09/2003 | CN1104907C Vibrio cholerae 01 (CVD111) and Non-01 (CVD112 and CVD112 RM) serogroup vaccine strain and methods of making same |
| 04/08/2003 | US6545142 Primers; nucleotide sequence |
| 04/08/2003 | US6545124 Antiproliferative agents |
| 04/08/2003 | US6544948 ΔP62, variants thereof, amino acid sequences coding therefor and their uses in gene therapy for cancer |
| 04/08/2003 | US6544792 Deactivation; Bacillus culture product |
| 04/08/2003 | US6544774 Morphological mutants of filamentous fungi |
| 04/08/2003 | US6544767 Genetic engineering; isolated polypeptide |
| 04/08/2003 | US6544761 Nucleotide sequences coding polypeptide for use in treatment of restenosis, arthritis and cancer |
| 04/08/2003 | US6544759 Polynucleotides encoding a novel growth factor which acts through ErbB-4 kinase receptor tyrosine |
| 04/08/2003 | US6544758 Methods for expressing endostatin protein |
| 04/08/2003 | US6544749 Antibodies to leukemia inhibitory factor and their use in immunoassays |
| 04/08/2003 | US6544748 Preparation of erythropoietin by endogenous gene activation |
| 04/08/2003 | US6544731 Genetic engineering; binding antibodies |
| 04/08/2003 | US6544522 Fusion proteins of mycobacterium tuberculosis antigens and their uses |
| 04/08/2003 | US6544519 Polypeptide originating in haemophilus paragallinarum and process for producing the same |
| 04/08/2003 | CA2205015C Method for producing biologicals in protein-free culture |
| 04/08/2003 | CA2191344C Synthetic peptide analogs of lung surfactant protein sp-c |
| 04/08/2003 | CA2184584C Vascular endothelial growth factor 2 |
| 04/08/2003 | CA2127470C Methods and compositions for diagnosing cat scratch disease and bacillary angiomatosis |
| 04/08/2003 | CA2109193C Gaba-a receptor subunits (.alpha.-2,.alpha.-3,.alpha.-5,.alpha.-6,.beta.-2) and transfected cells expressing them |
| 04/08/2003 | CA2107732C Retrovirus from the hiv group and its use |
| 04/08/2003 | CA2008368C Soluble molecule related to but distinct from icam-1 |
| 04/08/2003 | CA2006332C Method of detecting neurological disease or dysfunction |
| 04/03/2003 | WO2003027637A2 Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior |
| 04/03/2003 | WO2003027322A2 Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas |
| 04/03/2003 | WO2003027316A2 Methods of using 33751, a human potassium channel family member |
| 04/03/2003 | WO2003027315A2 Amidases, nucleic acids encoding them and methods for making and using them |
| 04/03/2003 | WO2003027305A2 Optimization of temperature shifting in high cell-density fermentations |
| 04/03/2003 | WO2003027300A2 Use of aminoglycoside resistance gene |
| 04/03/2003 | WO2003027289A1 Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 04/03/2003 | WO2003027288A1 Diagnostic method for cancer characterized in the detection of the deletion of g-csf exon 3 |
| 04/03/2003 | WO2003027285A1 Dna sequences for human angiogenesis genes |
| 04/03/2003 | WO2003027282A1 Adamts-15, -16, -17, -18 and -19 |
| 04/03/2003 | WO2003027266A2 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 04/03/2003 | WO2003027263A2 Proteins associated with cell growth, differentiation, and death |
| 04/03/2003 | WO2003027250A2 Monoclonal antibodies to the drug tilmicosin and a method for detecting the same |
| 04/03/2003 | WO2003027248A2 Antibody inhibitors of gdf-8 and uses thereof |
| 04/03/2003 | WO2003027240A2 Rhesus monkey, dog and ferret melanin-concentrating hormone type 1 receptor |
| 04/03/2003 | WO2003027239A2 Melanin-concentrating hormone receptor antagonist binding protein |
| 04/03/2003 | WO2003027228A2 Receptors and membrane-associated proteins |